4G/5G Polymorphism in the Promoter Region of the PAI-1 Gene Is not a Risk Factor for Familial Myocardial Infarction in Subjects over 45 Years

Francesco Burzotta; Augusto Di Castelnuovo; Concetta Amore; Andria D’Orazio; Maria Benedetta Donati; Licia Iacoviello

doi:10.1055/s-0038-1657731

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1997; 78(04): 1294-1295
DOI: 10.1055/s-0038-1657731

Letter to the Editor

Schattauer GmbH Stuttgart

4G/5G Polymorphism in the Promoter Region of the PAI-1 Gene Is not a Risk Factor for Familial Myocardial Infarction in Subjects over 45 Years

Authors

Francesco Burzotta

¹Istituto di Ricerche Farmacologiche Mario Negri, “Angela Valenti” Laboratory of Thrombosis Pharmacology, Department of Vascular Medicine and Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy
Augusto Di Castelnuovo

¹Istituto di Ricerche Farmacologiche Mario Negri, “Angela Valenti” Laboratory of Thrombosis Pharmacology, Department of Vascular Medicine and Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy
Concetta Amore

¹Istituto di Ricerche Farmacologiche Mario Negri, “Angela Valenti” Laboratory of Thrombosis Pharmacology, Department of Vascular Medicine and Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy
Andria D’Orazio

¹Istituto di Ricerche Farmacologiche Mario Negri, “Angela Valenti” Laboratory of Thrombosis Pharmacology, Department of Vascular Medicine and Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy
Maria Benedetta Donati

¹Istituto di Ricerche Farmacologiche Mario Negri, “Angela Valenti” Laboratory of Thrombosis Pharmacology, Department of Vascular Medicine and Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy
Licia Iacoviello

¹Istituto di Ricerche Farmacologiche Mario Negri, “Angela Valenti” Laboratory of Thrombosis Pharmacology, Department of Vascular Medicine and Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy

²Gaubius Laboratory, Leiden, The Netherlands

Abstract

PDF Download

PDF (358 kb)

References

References
1 Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268: 10739-10745
2 Eriksson P, Kallin B, van’t Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad USA 1995; 92: 1851-1855
3 Mansfield MW, Stickland MH, Grant PJ. Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 1995; 74: 1032-1034
4 Ossei-Geming N, Mansfield MW, Stickland MH, Wilson H, Grant PJ. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients charactrized by coronary angiography. Arterioscler Thromb Vasc Biol 1977; 17: 33-37
5 Ye S, Green FR, Scarabin PY, Nicaud BaraL, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP, Arveiler D, Henney AM, Cambien F. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost 1995; 74: 837-841
6 Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Miletich JP. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 1997; 95: 59-62
7 Roncaglioni MC, Santoro L, D’Avanzo B, Negri E, Nobili A, Ledda A, Pietropaolo F, Franzosi MG, La Vecchia C, Feruglio GA, Maseri A. on behalf of GISSI-EFRIM Investigators Role of family history in patients with myocardial infarction. An Italian case-control study. Circulation 1992; 85: 2065-2072
8 Falk G, Almqvist A, Nordenhem A, Svensson H, Wiman B. Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis 1995; 9: 170-174